On ECHEMI
Home > Drugs > Chronic hepatitis B
Chronic hepatitis B
Chronic hepatitis B is a common type of hepatitis B. Hepatitis B is characterized by a slow onset, with subclinical and chronic types being more common. Acute non-icteric HBsAg-positive patients are prone to chronic disease. The course of chronic hepatitis often exceeds half a year, and the disease can develop insidiously, often discovered during physical examinations. The symptoms vary, with recurrent attacks or prolonged illness. An estimated 5% to 10% of patients with acute hepatitis B develop into chronic hepatitis. The chronicity of acute hepatitis B depends mainly on the age of initial infection, immune status, and viral levels. Infections in infancy and childhood are prone to chronic disease. Patients using immunosuppressants and cytotoxic drugs, and patients with chronic renal failure on hemodialysis often lack obvious acute phase manifestations and have a protracted illness. Patients with very high serum levels of viral replication markers (HBeAg, HBV DNA) are more likely to develop chronic hepatitis.
  • Site of disease:

    liver
  • Infectious :

    Contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Lack of appetite fatigue liver disease appearance liver palm nausea
Related Drugs
Licorice Tablets
Manufacturer:

Jiangsu Morning Brand Pharmaceutical Group Co., Ltd.

ADEFOVIR DIPIVOXIL- adefovir dipivoxil_tablet
Indication: Adefovir dipivoxil tablets are indicated for the treatment of chronic hepatitis B in patients 12 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. This indication is based on histological, virological, biochemical, and serological responses in adult patients with HBeAg+ and HBeAg- chronic hepatitis B with compensated liver function, and with clinical evidence of lamivudine-resistant hepatitis B virus with either compensated or decompensated liver function. For patients 12 to less than 18 years of age, the indication is based on virological and biochemical responses in patients with HBeAg+ chronic hepatitis B virus infection with compensated liver function. Adefovir dipivoxil tablets are a nucleotide analogue indicated for the treatment of chronic hepatitis B in patients 12 years of age and older.
Manufacturer:

Apotex Corp.

TENOFOVIR DISOPROXIL FUMARATE- tenofovir disoproxil fumarate_tablet, film coated
Indication: Tenofovir disoproxil fumarate tablets are a nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor. (1) (1) Tenofovir disoproxil fumarate tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older. registered registered registered registered registered registered registered registered registered [See Warnings and Precautions (5. Tenofovir disoproxil fumarate tablets are indicated for the treatment of chronic hepatitis B in adults and pediatric patients 12 years of age and older. [See Clinical Studies (14. [See Adverse Reactions (6. [See Microbiology (12.
Manufacturer:

REMEDYREPACK INC.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.